Intelligent Group Ltd INTJ
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-2.28
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.4M | $2.6M | $2.6M | — | — |
| Cost of revenue | $858.9K | $1.0M | $576.9K | — | — |
| Gross profit | $1.5M | $1.6M | $2.1M | — | — |
| SG&A | $3.9M | $1.8M | $1.1M | — | — |
| Total operating expenses | $4.9M | $2.9M | $2.1M | — | — |
| Operating income | -$2.6M | -$324.7K | $529.3K | — | — |
| Pre-tax income | -$2.4M | -$141.6K | $589.0K | — | — |
| Income tax | $65.4K | $86.9K | $67.9K | — | — |
| Net income | -$2.3M | -$54.7K | $521.0K | — | — |
| EPS, basic | -2.28 | 0.00 | 0.05 | — | — |
| EPS, diluted | -2.28 | 0.00 | 0.05 | — | — |
| Shares, diluted (wtd. avg.) | 1.0M | 656,250 | 562,500 | 11.2M | 11.2M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | $8.7M | $8.2M | $3.3M | $2.0M | — |
| Receivables | $304.4K | $303.1K | $694.1K | — | — |
| Total current assets | $12.0M | $9.0M | $3.9M | — | — |
| Property, plant and equipment | $3.5K | $3.6K | $4.4K | — | — |
| Total assets | $12.3M | $9.2M | $4.4M | — | — |
| Short-term debt | $193.3K | $258.7K | $319.3K | — | — |
| Total current liabilities | $441.4K | $656.9K | $1.8M | — | — |
| Total liabilities | $656.2K | $915.6K | $2.2M | — | — |
| Retained earnings | -$445.5K | $1.9M | $1.9M | — | — |
| Total equity | $11.6M | $8.3M | $2.2M | — | — |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$22.9K | -$160.4K | $349.4K | — | — |
| Depreciation and amortisation | $2.1K | $825 | $22.0K | — | $411.6K |
| Stock-based compensation | $2.4M | — | — | — | — |
| Capital expenditure | $107.9K | — | $4.0K | — | — |
| Investing cash flow | -$2.6M | -$1.2M | $840 | — | — |
| Financing cash flow | $3.2M | $6.2M | $906.9K | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-037404.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $2.6M | $2.6M | $2.4M |
| Gross profit | — | — | $2.1M | $1.6M | $1.5M |
| Net income | — | — | $521.0K | -$54.7K | -$2.3M |
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $9.42B | 11.4x | -6.4% |
| G | Genpact LTD | $6.86B | 13.0x | 6.6% |
| FCN | FTI CONSULTING, INC | $4.34B | 19.1x | 2.4% |
| EXPO | EXPONENT INC | $3.68B | 37.4x | 4.2% |
| HURN | Huron Consulting Group Inc. | $3.17B | 33.5x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.09B | 81.4x | 56.4% |
| ICFI | ICF International, Inc. | $1.69B | 19.1x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $742.5M | 58.7x | 14.9% |